天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

LeterMovir-013

LeterMovir-013 Struktur
917389-37-8
CAS-Nr.
917389-37-8
Englisch Name:
LeterMovir-013
Synonyma:
-trimethyl-;(R)-Letermovir;LeterMovir-013;ent-Letermovir;Urea,N-ethyl-N,N'Lettermovir impurity B;LeterMovir Impurity 14;4-Quinazolineacetic acid, 8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-, (4R)-;2-[(4R)-8-fluoro-3-[2-methoxy-5-(trifluoromethyl)phenyl]-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3,4-dihydroquinazolin-4-yl]acetic acid
CBNumber:
CB08378044
Summenformel:
C29H28F4N4O4
Molgewicht:
572.55
MOL-Datei:
917389-37-8.mol

LeterMovir-013 Eigenschaften

Siedepunkt:
706.5±70.0 °C(Predicted)
Dichte
1.37±0.1 g/cm3(Predicted)
pka
4.00±0.10(Predicted)

Sicherheit

LeterMovir-013 Chemische Eigenschaften,Einsatz,Produktion Methoden

LeterMovir-013 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


LeterMovir-013 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 26)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
ShenZhen H&D Pharmaceutical Technology Co., LTD
+8618627948422
sale@hdimpurity.com China 3389 58
Arizest(Shanghai)Pharmatech Co., Ltd
+86-021-60753300
3652837972@qq.com China 220 58
Guangzhou CATO Research Chemicals Inc.
+86-020-81960175-617 +8615602392859
Intermediate@cato-chem.com China 8322 58
Moxin Chemicals
+8617320513646
mike@molcoo.com China 9511 58
Beijing Comparison Pharmaceutical Technology Co., Ltd 010-010-52878169 15801002657
sales@bjcomparison.com China 4719 58
Shanghai Lollane Biological Technology Co.,Ltd. 021-52996696,15000506266 15000506266
China 4574 55
Shanghai Xiang Xin Industrial Co., Ltd. 021-50211651 13651607026
sales@xxgmpharm.com China 481 58
Shijiazhuang yaoBo Pharmaceutical Co., Ltd. 15633056635
2880679888@qq.com China 2967 58
Shanghai Yu Ben Biotechnology Co., Ltd. 15502154572
yuben012@sina.com China 506 58
Shandong Chengchuang Blue Sea Pharmaceutical Technology Co., Ltd. 0531-58897130 15508676053
drug_impurity@sdcclh.com China 2017 58

  • LeterMovir-013
  • (R)-Letermovir
  • 4-Quinazolineacetic acid, 8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-, (4R)-
  • -trimethyl-
  • Urea,N-ethyl-N,N'
  • ent-Letermovir
  • Lettermovir impurity B
  • 2-[(4R)-8-fluoro-3-[2-methoxy-5-(trifluoromethyl)phenyl]-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3,4-dihydroquinazolin-4-yl]acetic acid
  • LeterMovir Impurity 14
  • 917389-37-8
Copyright 2019 ? ChemicalBook. All rights reserved